drugset
drugset / Trial / NCT00592774

Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)

NCT00592774 ↗

Phase 2 Completed 146 enrolled Eisai Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine the efficacy and safety of Perampanel (E2007) in patients with Post-Herpetic Neuralgia (PHN).

Timeline

Start
2008-01
Primary completion
2008-12
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Perampanel Small molecule 8 mg —

Indications

neuralgia